In vivo effects of rufloxacin and ciprofloxacin on T-cell subsets and tumor necrosis factor production in mice infected with Bacteroides fragilis.

od Gollapudi, S V, Chuah, S K, Harvey, T, Thadepalli, H D, Thadepalli, H
Izdano 1993

Clinical evaluation of mezlocillin.

od Thadepalli, H, Rao, B
Izdano 1979

Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.

od Bansal, M B, Thadepalli, H
Izdano 1987

Antimicrobial effect of beta-lactam antibiotic combinations against Bacteroides fragilis in vitro.

od Bansal, M B, Thadepalli, H
Izdano 1983

Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.

od Thadepalli, H, Gollapudi, S V, Chuah, S K
Izdano 1986

Anaerobic lung infections treated with doxycycline.

od Thadepalli, H., Webb, D., Huang, J. T.
Izdano 1978

Augmentation of the in vitro activity of azlocillin against Bacteroides fragilis by clavulanic acid.

od Bansal, M B, Chuah, S K, Thadepalli, H
Izdano 1984

Effect of ciprofloxacin on mitogen-stimulated lymphocyte proliferation.

od Gollapudi, S V, Prabhala, R H, Thadepalli, H
Izdano 1986

In vitro activity of pipecolic acid amide of clindamycin (U-57930E) on anaerobic bacteria compared with those of clindamycin, cefoxitin, and chloramphenicol.

od Dhawan, V K, Bansal, M B, Thadepalli, H
Izdano 1982

Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis.

od Gollapudi, S V, Gupta, A, Thadepalli, H, Perez, A
Izdano 1988

Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 inhibit mitogen-induced human mononuclear cell proliferation.

od Gollapudi, S V, Vayuvegula, B, Gupta, S, Fok, M, Thadepalli, H
Izdano 1986

Animal model for anaerobic lung abscess.

od Kannangara, D W, Thadepalli, H, Bach, V T, Webb, D
Izdano 1981

Polymicrobial septicemia after liver biopsy.

od Dhawan, V K, Thadepalli, H, Ulmer, D D, Akhtar, A
Izdano 1983

In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867).

od Prabhala, R H, Rao, B, Marshall, R, Bansal, M B, Thadepalli, H
Izdano 1984

In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria.

od Prabhala, R H, Thadepalli, H, Rao, B, Bansal, M B, Marshall, R
Izdano 1985

Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments.

od Gorbach, S L, Mayhew, J W, Bartlett, J G, Thadepalli, H, Onderdonk, A B
Izdano 1976

Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice.

od Thadepalli, H, Chuah, S K, Reddy, U, Hanna, N, Clark, R, Polzer, R J, Gollapudi, S
Izdano 1997

Rapid differentiation of bacterial meningitides by direct gas-liquid chromatography.

od Thadepalli, H, Gangopadhyay, P K, Ansari, A, Overturf, G D, Dhawan, V K, Mandal, A K
Izdano 1982

In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.

od Thadepalli, H, Reddy, U, Chuah, S K, Thadepalli, F, Malilay, C, Polzer, R J, Hanna, N, Esfandiari, A, Brown, P, Gollapudi, S
Izdano 1997